PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report

PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report

Summary

PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PDL Biopharma, Inc. (PDL or 'the company') manages a portfolio of patents and royalty assets that include Queen et al. patents and license agreements with various pharmaceutical and biotechnology companies, and royalty and other acquired assets. It offers financing solutions and non-dilutive growth capital to public and private healthcare companies. PDL provides companies, academic institutions, and inventors with an immediate financial monetization of royalty streams for acquiring new income-generating assets. The company also carries out the humanization of monoclonal antibodies for facilitating the discovery of targeted treatments for cancer and other immunologic diseases. The company is headquartered in Reno, Nevada, the US.

Scope

• Detailed information on PDL Biopharma, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting PDL Biopharma, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of PDL Biopharma, Inc. including a breakdown and examination of key business segments
• Intelligence on PDL Biopharma, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about PDL Biopharma, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of PDL Biopharma, Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess PDL Biopharma, Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on PDL Biopharma, Inc.'s business structure, strategy and prospects.